Upper Tract Urological Laparoendoscopic Single-Site Surgery (LESS).
Volkan Tugcu1, Arda Atar1, Selcuk Sahin1
1Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
JSLS : Journal of the Society of Laparoendoscopic Surgeons
|December 10, 2015
Summary
Upper tract laparoendoscopic single-site surgery (LESS) shows intermediate-term safety and effectiveness for various urologic conditions. Experienced teams can achieve good outcomes, though complications like strictures and urinomas require monitoring.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Surgical Outcomes
Background:
- Laparoendoscopic single-site surgery (LESS) is an advanced minimally invasive technique.
- Upper tract procedures present unique surgical challenges.
- Evaluating intermediate-term outcomes is crucial for establishing safety and efficacy.
Purpose of the Study:
- To report intermediate-term outcomes of upper tract urologic LESS procedures.
- To assess the safety and effectiveness of LESS in various upper tract conditions.
- To analyze complication rates associated with LESS.
Main Methods:
- Retrospective review of 107 upper tract LESS cases (2008-2012).
- Procedures included pyeloplasty, ureterolithotomy, nephrectomy, and cyst decortication.
- Perioperative data, conversion rates, and complication rates were analyzed.
Main Results:
- Median follow-up ranged from 14 to 28 months.
- Major complications occurred in 8 patients, including intraoperative bleeding and bowel injury.
- Postoperative complications included ureteral strictures and urinoma formation.
Conclusions:
- Upper tract LESS can be safe and effective when performed by experienced surgeons.
- The procedure is technically demanding.
- Longer follow-up studies are needed to further evaluate LESS safety and efficacy.
